Pediatrics & Therapeutics
Open Access
ISSN: 2161-0665
+44 1478 350008
ISSN: 2161-0665
+44 1478 350008
Fernando Gabriel Manzur Jattin
Universidad de Cartagena, Colombia
Scientific Tracks Abstracts: Pediat Therapeut
Canakinumab is a totally human monoclonal antibody anti-IL-1�?² developed by Novartis, whose mode of action is based on the neutralization of IL-1�?² signaling, which leads to suppression of inflammation in patients with autoimmune disorders. The IL-1�?² acts as a mediator of the peripheral immune response during infection and inflammation. By the antigen-antibody binding, canakinumab inhibits the action of IL1-�?² avoiding its pro-inflammatory effects. Currently, it is being evaluated as a new possible agent directed against IL-1�?², with the goal of reducing the rate of cardiovascular events and new onset diabetes.
Fernando Gabriel Manzur Jattin, has completed his Master´s degree at European board accreditation in cardiology: Exploring the clinical value of innovaation in lipid management, Universidad de Sevilla: Maestria en ensayos clinicos, Universidad Católica San Antonio: Master universitario en avances en cardiologia, Maestria en imagenes cardiovasculares, Universidad de Padova. And postdoctoral studies from Harvard medical school: Evaluating the value of cardiovascular therapeutic, Sociedad latinoamericana de hipertensión, Consenso latinoamericano de hipertensión sindrome metabólico y diabetes mellitus: Guias latinoamericanas de hta. The European Board For Accreditation in Cardiology: 21 CME, Universidad De Harvard: ENSAYO SOLID TIMI 52, Sociedad Europea de Cardiologia: Terapia de lipidos, Sociedad Chilena De Cardiologia: Ecocardiografia Avanzada, Universidad Del Magdalena: Experto En Buenas Practicas Clinicas, The European Board For Acreditation in Cardiology EBAC: International CME Program in Cardiology University Of Miami: Curso de Postgrado en Cardiologia Clinica, Mayo Clinic: A Case Based Approach to Ischemic Heart Disease Management. He is member of: Gobernador, Ispc, Ispc, Fellow Facc, American college Of Cardiology, Miembro Correspondiente, Sociedad Chilena De Cardiologia, Fellow Honorario, Sociedad Internacional De Ecocardiografia, Ex Presidente Y Miembro Honorario, Sociedad Colombiana De Cardiologia, Miembro Correspondiente, Sociedad Brasilera De Cardiologia, Miembro Correspondiente, Sociedad Argentina De Cardiologia, Miembro Correspondiente, Federación Argentina De Cardiologia, Socio Correspondiente, Sociedad Chilena De Cardiologia, Miembro Activo Colegiado, Federación Médica Colombiana, Socio Numerario, Sociedad Castellana De Cardiologia, Miembro Numerario, Sociedad Espanola De Cardiologia, Miembro Consejo Superior, Universidad De Cartagena, Fellow European Society Of Cardiology, Sociedad Europea De Cardiologia, Miembro Emérito Sociedad Colombiana de Cardiologia, Miembro Honorario, Federación Diabetologica De Colombia, Miembro Honorario, Sociedad Dominicana De Cardiologia, Presidente De Los Consejos Cientificos De La Sociedad Interamericana De Cardiologia, Sociedad Ineraméricana de Cardiologia. He has published more than 67 papers in reputed journals, and written 11 books.
Email: fmanzur1954@hotmail.com